Calian Group (TSE:CGY) Price Target Raised to C$60.00

Calian Group (TSE:CGY) had its price objective raised by Royal Bank Of Canada from C$58.00 to C$60.00 in a research note published on Friday morning,BayStreet.CA reports. The firm currently has an outperform rating on the stock.

Other research analysts have also issued research reports about the company. Canadian Imperial Bank of Commerce increased their target price on Calian Group from C$65.00 to C$76.00 in a research report on Friday. Desjardins upped their price target on Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Canaccord Genuity Group increased their price objective on Calian Group from C$63.00 to C$80.00 in a report on Friday. Finally, Ventum Financial boosted their target price on shares of Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a report on Tuesday, January 27th. Six investment analysts have rated the stock with a Buy rating, According to MarketBeat, Calian Group has a consensus rating of “Buy” and an average target price of C$74.83.

Calian Group Trading Up 6.7%

Shares of CGY opened at C$70.60 on Friday. Calian Group has a 1-year low of C$37.70 and a 1-year high of C$71.92. The company has a current ratio of 1.29, a quick ratio of 1.20 and a debt-to-equity ratio of 39.54. The firm’s 50-day moving average price is C$60.38 and its 200-day moving average price is C$54.15. The firm has a market capitalization of C$805.62 million, a price-to-earnings ratio of 30.96, a PEG ratio of 2.50 and a beta of 0.70.

Calian Group (TSE:CGY) last released its quarterly earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. The company had revenue of C$208.00 million during the quarter. Sell-side analysts anticipate that Calian Group will post 4.9475219 EPS for the current year.

Calian Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Wednesday, March 11th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend is Wednesday, February 25th. Calian Group’s dividend payout ratio (DPR) is 49.12%.

Calian Group News Roundup

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.